SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-K: TO ANNUAL REPORT ON FORM 10-K FOR YEAR

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-K, Date: 2011-04-11
Original SEC Filing: Click here


Webplus: SKBI/20110411/10-K/1/000.htm SEC Original: v218099_10k.htm
TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED DECEMBER 31, 2010 Page 3 PART I Item 1. Business 3 Item 2. Properties 13 Item 3. Legal Proceedings 14 PART II 16 Item 5. 16 Item 7. Managements Discussion and Analysis of Financialnditions and Results of Operations 17 Item 8.




Webplus: SKBI/20110411/10-K/4_EX-31.1/000.htm SEC Original: v218099_ex31-1.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light




Webplus: SKBI/20110411/10-K/5_EX-31.2/000.htm SEC Original: v218099_ex31-2.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in




Webplus: SKBI/20110411/10-K/6_EX-32.1/000.htm SEC Original: v218099_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer April 11, 2011




Webplus: SKBI/20110411/10-K/7_EX-32.2/000.htm SEC Original: v218099_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer April 11, 2011



Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-K, Date: 2011-04-11CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE

Home Page Forums

By | 2016-02-05T03:44:16+00:00 April 11th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar